By Centre national de la recherche scientifique (CNRS)
Capitalising on a patent always starts with negotiating a licensing contract, which delivers the right of use of the patent in a specific field and region with a view to commercialisation. Every year, our teams and those of our partners sign around 200 licensing contracts on behalf of the CNRS. All patents that come out of a CNRS-supervised laboratory are intended to be exploited, but since they are still far from the market, it’s up to us to build strong links with companies to get them there, he explains. A molecule obtained in a laboratory may need a number of additional developments before it can be mass produced in a factory. The CNRS delivers the development of effective solutions based on its patented technologies. Research organisations that have contributed patents are remunerated fairly and reasonably so that the laboratories and teams can continue to pursue their programmes of basic research. CNRS teams commit to implementing a licence that suits the economic and technological developments of their partners in industry. This is so they can jointly build a licensing plan, adjusting the scope of the licence to fit the project, with financial conditions that are suitable for the project and are determined on the basis of comparable projects.
